Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1γ autoantibodies

Yuji Hosono; Brandon Sie; Iago Pinal-Fernandez; Katherine Pak; Christopher A. Mecoli; Maria Casal-Dominguez; Blake M. Warner; Mariana J. Kaplan; Jemima Albayda; Sonye K. Danoff; Thomas E. Lloyd; Julie Paik; Eleni Tiniakou; Jose C. Milisenda; Josep M. Grau-Junyent; Albert Selva-O’Callaghan; Lisa Christopher-Stine; H. Benjamin Larman; Andrew L. Mammen

doi:10.1101/2022.02.28.22271555

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1γ autoantibodies

Yuji Hosono, Brandon Sie, Iago Pinal-Fernandez, Katherine Pak, Christopher A. Mecoli, Maria Casal-Dominguez, Blake M. Warner, Mariana J. Kaplan, Jemima Albayda, Sonye K. Danoff, Thomas E. Lloyd, Julie Paik, Eleni Tiniakou, Jose C. Milisenda, Josep M. Grau-Junyent, Albert Selva-O’Callaghan, Lisa Christopher-Stine, H. Benjamin Larman, Andrew L. Mammen

doi: https://doi.org/10.1101/2022.02.28.22271555

Yuji Hosono

1Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD

M.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brandon Sie

3Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD

B.S.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Iago Pinal-Fernandez

1Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD

2Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

8Faculty of Health Sciences and Faculty of Computer Science, Multimedia and Telecommunications, Universitat Oberta de Catalunya, Barcelona, Spain

M.D., Ph.D.,Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katherine Pak

1Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD

M.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christopher A. Mecoli

7Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

M.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Casal-Dominguez

1Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD

2Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

M.D., Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Blake M. Warner

5Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA

6Sjogren’s Clinic, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA

D.D.S., Ph.D., M.P.H.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mariana J. Kaplan

4Systemic Autoimmunity Branch, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD, USA

M.D., Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jemima Albayda

7Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

M.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sonye K. Danoff

7Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

M.D., Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas E. Lloyd

2Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

M.D., Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julie Paik

7Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

M.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eleni Tiniakou

7Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

M.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jose C. Milisenda

9Clinic Hospital and the University of Barcelona, Barcelona, Spain

M.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Josep M. Grau-Junyent

9Clinic Hospital and the University of Barcelona, Barcelona, Spain

M.D., Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Albert Selva-O’Callaghan

10Vall d’Hebron Hospital and Autonomous University of Barcelona, Spain

M.D., Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lisa Christopher-Stine

2Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

M.D., M.P.H.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

H. Benjamin Larman

3Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD

Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrew L. Mammen

1Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD

2Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

7Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

M.D., Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: andrew.mammen@nih.gov

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Article usage

Article usage: March 2022 to December 2024

	Abstract	Full	Pdf
Mar 2022	491	29	77
Apr 2022	141	8	29
May 2022	87	1	12
Jun 2022	115	4	35
Jul 2022	43	2	5
Aug 2022	58	4	6
Sep 2022	68	0	11
Oct 2022	46	5	28
Nov 2022	40	14	24
Dec 2022	33	6	8
Jan 2023	30	12	16
Feb 2023	19	13	5
Mar 2023	33	12	14
Apr 2023	27	6	13
May 2023	14	8	11
Jun 2023	11	8	1
Jul 2023	11	7	5
Aug 2023	28	12	5
Sep 2023	18	8	6
Oct 2023	10	5	3
Nov 2023	25	11	8
Dec 2023	13	3	10
Jan 2024	8	3	4
Feb 2024	9	2	4
Mar 2024	8	3	6
Apr 2024	11	4	14
May 2024	2	1	1
Jun 2024	20	8	10
Jul 2024	17	3	23
Aug 2024	5	5	8
Sep 2024	10	2	10
Oct 2024	6	0	5
Nov 2024	7	3	6
Dec 2024	3	0	9

View the discussion thread.

PreviousNext

Posted March 01, 2022.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1γ autoantibodies

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1γ autoantibodies

medRxiv 2022.02.28.22271555; doi: https://doi.org/10.1101/2022.02.28.22271555

Share This Article:

Citation Tools

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1γ autoantibodies

medRxiv 2022.02.28.22271555; doi: https://doi.org/10.1101/2022.02.28.22271555

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Rheumatology

Subject Areas

All Articles

Addiction Medicine (399)
Allergy and Immunology (708)
Anesthesia (201)
Cardiovascular Medicine (2931)
Dentistry and Oral Medicine (333)
Dermatology (249)
Emergency Medicine (439)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1035)
Epidemiology (12734)
Forensic Medicine (12)
Gastroenterology (827)
Genetic and Genomic Medicine (4578)
Geriatric Medicine (417)
Health Economics (729)
Health Informatics (2914)
Health Policy (1069)
Health Systems and Quality Improvement (1077)
Hematology (388)
HIV/AIDS (924)
Infectious Diseases (except HIV/AIDS) (14094)
Intensive Care and Critical Care Medicine (846)
Medical Education (424)
Medical Ethics (115)
Nephrology (468)
Neurology (4345)
Nursing (236)
Nutrition (638)
Obstetrics and Gynecology (803)
Occupational and Environmental Health (734)
Oncology (2266)
Ophthalmology (645)
Orthopedics (258)
Otolaryngology (324)
Pain Medicine (279)
Palliative Medicine (83)
Pathology (500)
Pediatrics (1196)
Pharmacology and Therapeutics (504)
Primary Care Research (495)
Psychiatry and Clinical Psychology (3751)
Public and Global Health (6932)
Radiology and Imaging (1526)
Rehabilitation Medicine and Physical Therapy (900)
Respiratory Medicine (915)
Rheumatology (437)
Sexual and Reproductive Health (443)
Sports Medicine (385)
Surgery (487)
Toxicology (60)
Transplantation (210)
Urology (180)